Very average results to say the least.. Will hold for another quarter to see what they can pull out of the bag. It is now obvious the director buys were to simply help a very quick falling share price.
- Forums
- ASX - By Stock
- FLN
- Ann: 2017 Interim Financial Report & Appendix 4D
FLN
freelancer limited
Add to My Watchlist
0.00%
!
27.0¢

Ann: 2017 Interim Financial Report & Appendix 4D, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
27.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $121.7M |
Open | High | Low | Value | Volume |
27.0¢ | 28.0¢ | 25.5¢ | $14.03K | 52.29K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4877 | 25.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.5¢ | 400 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4877 | 0.255 |
1 | 10000 | 0.240 |
1 | 9973 | 0.235 |
1 | 189132 | 0.230 |
1 | 10000 | 0.215 |
Price($) | Vol. | No. |
---|---|---|
0.285 | 400 | 1 |
0.290 | 18657 | 1 |
0.350 | 9428 | 1 |
0.400 | 18984 | 1 |
0.000 | 0 | 0 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
FLN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online